USPTO’s COVID-19 Prioritized Examination Pilot Program
“Independent inventors and small businesses are often the difference-makers when it comes to cutting-edge innovation and the growth of our economy. They are also in […]
Articles by Krishnam Goyal
Interpretation of Art. 53(b) of the European Patent Convention inches closer to the interpretation of Section 3(j) of the Indian patents act, 1970
On May 14, 2020, the Enlarged Board of Appeals of the European Patent Organisation (EPO) has issued an opinion [click to access] about the interpretation […]
Public health lawfully outlaws the patent rights: a story of March-in rights!
My previous posts on the open-source innovation read with Doha style compulsory licensing and revocation in the public interest were exhaustive on the access to […]
USPTO initiates an online platform for voluntary licensing
A new web-based intellectual property (IP) marketplace platform, Patents 4 Partnerships, is introduced by USPTO on May 4, 2020. It provides the searchable database of patents […]
From the bolar provision to the issuance of the compulsory license and revocation in the public interest – Remdesivir drug of Gilead is a complete course on patent law
The time since the experts have suggested “Remdesivir” as a possible drug to fight against COVID-19, global debate over obtaining this drug is started. The […]
Open Source Innovation in the pharmaceuticals: Is that all for public health?
Dear Readers, I hope you are reading this post in your good health and essentially operable outdoor conditions. In this unfortunate time, when the world […]